Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib.
Saved in:
| Title: | Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib. |
|---|---|
| Authors: | Banasavadi-Siddegowda YK; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Namagiri S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Otani Y; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA., Sur H; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Rivas S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Bryant JP; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Shellbourn A; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Rock M; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Chowdhury A; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Lewis CT; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA., Shimizu T; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA., Walbridge S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Kumarasamy S; Department of Biomedical Sciences Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA., Shah AH; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Lee TJ; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA., Maric D; Flow and Imaging Cytometry Core Facility, NINDS, NIH, Bethesda, Maryland, USA., Yan Y; Department of Surgery, Northwestern University, Chicago, Illinois, USA., Yoo JY; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA., Kumbar SG; Department of Orthopedic Surgery, University of Connecticut Health, Farmington, Connecticut, USA., Heiss JD; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Kaur B; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2022 Jun 20; Vol. 4 (1), pp. vdac095. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
